Advertisement
Screener

Axogen, Inc. (AXGN) Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31)

3.2 / 5 stars · 63/98 Roast Me

Axogen, Inc. Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31)

Axogen, Inc. (AXGN) reported Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31) of $0 for the 3-month period ending 2013-06-30, per its 10-Q filed 2013-08-14.

Discontinued › Expense Statement

us-gaap:IncomeTaxExpenseBenefitContinuingOperations · last filed 2013-08-14

  • Axogen, Inc. income tax expense (benefit), continuing operations (deprecated 2013-01-31) for the quarter ending 2013-06-30 was $0.00, a 100.00% decline year-over-year.
  • Axogen, Inc. income tax expense (benefit), continuing operations (deprecated 2013-01-31) for the quarter ending 2012-06-30 was $736.00K.
  • Axogen, Inc. income tax expense (benefit), continuing operations (deprecated 2013-01-31) for fiscal 2012 was $738.00K.
  • Axogen, Inc. income tax expense (benefit), continuing operations (deprecated 2013-01-31) for fiscal 2011 was $0.00.
Period endIncome Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31) 3 monthIncome Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31) 6 monthIncome Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31) 12 month
2013-06-30$0.00
10-Q · filed 2013-08-14
$0.00
10-Q · filed 2013-08-14
2012-12-31$738.00K
10-K/A · filed 2013-08-07
2012-06-30$736.00K
10-Q · filed 2013-08-14
$736.00K
10-Q · filed 2013-08-14
2011-12-31$0.00
10-K/A · filed 2013-08-07

Similar stocks

Stock NameCountryMarket CapPE Ratio
BIOLIFE SOLUTIONS INC (BLFS)United States$1.887B23.80
TransMedics Group, Inc. (TMDX)United States$2.911B15.17
CONMED Corp (CNMD)United States$1.353B26.72
Ceribell, Inc. (CBLL)United States$0.916B-11.27
LivaNova PLC (LIVN)$4.158B24.01
Integer Holdings Corp (ITGR)United States$4.289B25.17
CapsoVision, Inc (CV)United States$0.310B-12.68
Electromed, Inc. (ELMD)United States$0.233B31.13
EDAP TMS SA (FOCL)$0.171B
Stereotaxis, Inc. (STXS)United States$0.130B-7.53